the main problem is that Koos can Lander can not find money to fund any clinical trial after IND. There has been no word yet on that supposed 3rd Q start of Hemaxellerate and it's clear as to why. Because Lander failed in finding money to fund the trial. Pure and simple.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.